CTNNB1 and neoplasm: We found that 60% (18/30) of samples with high PLK1 expression (above median PLK1 TPM of all tumor samples) also had high β-catenin (CTNNB1) expression (above median CTNNB1 TPM of all tumor samples) (Figure 3).